- TraderTV Research
- Posts
- Trader TV Watchlist - April 16, 2025
Trader TV Watchlist - April 16, 2025
Wednesday April 16, 2025
Welcome to the TraderTV Live Morning Research Note. Here's what's making major moves in the market today.
TraderTV.LIVE™ features a daily live trading broadcast, professional education and an active community of more than 450,000 subscribers. Join us on YouTube every weekday from 8:30am to 4:30pm EST for the first and only professional trading show on YouTube Live!
Economic Events:
0830 - Retail sales m/m for March: Expected 1.3%; Prior 0.2%
0830 - Core retail sales m/m for March: Expected 0.4%; Prior 0.3%
0915 - Industrial production m/m for March: Expected -0.2%; Prior 0.7%
1000 - NAHB housing market index for April: Expected 38; Prior 39
1000 - Business inventories m/m for December: Expected 0.2%; Prior 0.3%
1200 - Fed’s Hammack speaks
1330 - Fed Chair Powell speaks
Premarket Trading:
Trading Higher ($): AAL, NEM, SERV
Trading Lower ($): NVDA, ASML, PLTR
Earnings Today:
Premarket: ASML, ABT, PGR
Post-market: AA, CSX, KMI
In The News
NVIDIA Corp (NVDA)
-6.55%
On Tuesday evening, the company disclosed that it was informed by the U.S. government that it will need a license to export its H20 chips and similar high-performance circuits to China due to national security concerns. As a result, NVIDIA expects up to $5.5 billion in charges related to inventory and purchase commitments in its upcoming Q1 fiscal 2026 results. The Wall Street Journal reported that new exports curbs have been placed on chips from both Nvidia and AMD, citing the US administration.
Alphabet Inc (GOOGL)
-2.11%
The company is facing a £5 billion ($6.6 billion) class action lawsuit in the U.K., accusing it of abusing its dominance in the online search market to overcharge advertisers and suppress competition. Filed by competition law expert Or Brook, the suit claims that U.K. businesses had little choice but to use Google Ads. Google has denied wrongdoing and asserted its intention to fight the case vigorously.
ASML Holding NV (ASML)
-4.52%
Trading lower premarket following its Q1 2025 earnings. The company reported GAAP earnings of 6 euros per share, above estimates of 5.79 euros, while sales of 7.742 billion euros came in shy of the estimated 7.824 billion euros. ASML guided Q2 net sales between 7.2 billion and 7.7 billion euros, missing analyst estimates of 7.73 billion euros; the midpoint of its FY 2025 revenue guidance was in-line with estimates.
Tesla Inc (TSLA)
-1.97%
Trading lower premarket after Reuters reported that the company has halted plans to import Chinese components for its Cybercab and Semi trucks. The decision was reportedly made in response to increased U.S. tariffs under President Trump and could result in the disruption of key growth initiatives in autonomous vehicles. Tesla has faced declining sales, rising competition, and geopolitical headwinds as of late.
Meta Platforms Inc (META)
-1.92%
On watch as the FTC antitrust trial against the company continues. CEO Mark Zuckerberg testified on both Monday and Tuesday, with his testimony on Tuesday revealing that Snap rejected a $6 billion buyout offer from Facebook in 2013. The FTC has argued that Meta used acquisitions to stifle competition, and this trial could force Meta to divest Instagram and WhatsApp.
United Airlines Holdings Inc (UAL)
+6.87%
Gapping up after reporting Q1 2025 earnings, with earnings of $0.91 per share beating estimates of $0.76; revenue of $13.213 billion narrowly missed estimates of $13.257 billion. The company guided Q2 adjusted earnings between $3.25 and $4.25, compared to estimates of $3.99, and provided two EPS guides for fiscal 2025. United expects to post earnings between $11.50 and $13.50 per share for the year in a “stable environment” but projects earnings between $7 and $9 per share in a “recessionary scenario”; analysts were expecting guidance of $10.83 per share.
Chinese ADRs
-2.15%
Trading lower as a group following a weak overnight session in China, with the tech-heavy Hang Seng Index closing nearly 2% lower. On Tuesday evening, the White House released a fact sheet on the US administration’s tariff actions as they relate to national security. According to the fact sheet, China could face “up to a 245% tariff on imports to the United States as a result of its retaliatory actions” towards previous tariffs announced by the administration; the tariff currently stands at 145%.
BABA, BILI, BIDU, PDD, JD, LI, NIO, XPEV, FXI, KWEB
Lyft Inc (LYFT)
+2.39%
Trading higher premarket after announcing its planned acquisition of European ride-hailing platform Free Now for €175 million ($199 million), marking its first expansion into the European market. The acquisition, which is set to close in the back half of 2025, will give Lyft access to over 150 cities across nine countries, significantly boosting its international presence.
Interactive Brokers Group Inc (IBKR)
-7.97%
Gapping down after its Q1 earnings report, during which the company announced a quarterly dividend increase and a four-for-one stock split as of the evening of June 16. Interactive Brokers reported adjusted earnings of $1.88 per share, missing estimates of $1.92, though sales of $1.43 billion exceeded expectations of $1.39 billion. The company reported year-over-year increases of at least 20% in customer accounts, customer equity, and commission revenue, among other segments.
Gold and Mineral Stocks
+3.74%
Trading sharply higher as a group as traders digest a slew of headlines in this space. Gold is trading near all-time highs and surpassed the $3300 level for the first time as of Wednesday morning. Meanwhile, mineral stocks continue to trade higher after President Donald Trump issued an executive order directing an investigation under Section 232 to assess whether imports of critical minerals pose a national security risk. This order could potentially lead to new tariffs.
GOLD, NEM, HMY, GDX, TMC
BriaCell Therapeutics Corp (BCTX)
+34.67%
Gapping up after announcing new Phase 2 data showing that its Bria-IMT regimen combined with checkpoint inhibitors achieved a median overall survival of 17.3 months in triple-negative breast cancer patients. This outcome exceeds the historical 14.4-month survival seen with TRODELVY. The stock has a float of 2.36 million shares, roughly 5.53% of which are sold short.